Using a xenografted mouse model, we have previously explored the anti-lung cancer therapeutic potential of an ex vivo-expanded clonal cytotoxic T cell line (CTL) [12], TAK-1, which specifically recognizes the WT1235–243 nonamer epitope in the context of HLA-A*2402 [13]. This evidence concerns the gene HLA-A and lung cancer.